Upon completing his education, he began his professional career with Quintiles, a leading contract research organization. Over the next five years, he honed his skills in the pharmaceutical and biotechnology sectors in India. His expertise and dedication opened doors to international opportunities, allowing him to work in the United States on a work permit visa.

During his 18 years in the industry, he gained invaluable experience collaborating with cutting-edge drug development companies. His efforts contributed to the approval of two innovative drug molecules by the US FDA, marking significant milestones in his career. These achievements fueled his passion for making a difference in the healthcare industry.

In August 2022, he embarked on a new journey by founding PAR Clinical. As an entrepreneur, he faces the dual challenges and opportunities that come with building a company from the ground up. His focus remains steadfast on organic growth, with a vision to improve patient lives by developing and implementing new strategies in the healthcare sector.

His entrepreneurial journey is driven by a deep commitment to innovation and a desire to contribute to the advancement of medical science. Through PAR Clinical, he aims to lead transformative changes in the industry, staying true to his mission of enhancing patient outcomes and pioneering new healthcare solutions.